Risk analysis for outpatient experimental infection as a pathway for affordable RSV vaccine development.
Siegal EZ. et al, (2025), NPJ vaccines, 10
A 5-transcript signature for discriminating viral and bacterial etiology in pediatric pneumonia
Viz-Lasheras S. et al, (2025), iScience, 28
A diagnostic host-specific transcriptome response for Mycoplasma pneumoniae pneumonia to guide pediatric patient treatment.
Viz-Lasheras S. et al, (2025), Nature communications, 16
Evaluation of naturally occurring IgG anti-Vi antibody titers as predictors and correlates of typhoid fever in Dhaka, Bangladesh.
Khanam F. et al, (2025), BMC infectious diseases, 25
Predictors of severity of SARS-CoV-2 infections in Brazil: Post hoc analyses of a randomised controlled trial
Conlin K. et al, (2025), Vaccine, 45, 126582 - 126582
The respiratory microbiome is linked to the severity of RSV infections and the persistence of symptoms in children.
Kristensen M. et al, (2024), Cell reports. Medicine, 5
The respiratory syncytial virus vaccine and monoclonal antibody landscape: the road to global access.
Terstappen J. et al, (2024), The Lancet. Infectious diseases, 24, e747 - e761
Biomarkers of vaccine safety and efficacy in vulnerable populations: Lessons from the fourth international precision vaccines conference.
Amodio D. et al, (2024), Vaccine, 43
GeM-LR: Discovering predictive biomarkers for small datasets in vaccine studies.
Lin L. et al, (2024), PLoS computational biology, 20
New programme to prevent bronchiolitis in infants
Pollard AJ. et al, (2024), Archives of Disease in Childhood
5-year vaccine protection following a single dose of Vi-tetanus toxoid conjugate vaccine in Bangladeshi children (TyVOID): a cluster randomised trial
Qadri F. et al, (2024), The Lancet, 404, 1419 - 1429
Characterising the molecular epidemiology of human parechovirus in young infants in the UK and Canada
Kadambari S. et al, (2024), Journal of Clinical Virology, 174, 105715 - 105715
Oxford Vaccine Hesitancy Scale (OVHS): a UK-based and US-based online mixed-methods psychometric development and validation study of an instrument to assess vaccine hesitancy
Kantor J. et al, (2024), BMJ Open, 14, e084669 - e084669
Respiratory Syncytial Virus-related Community Chronic Obstructive Pulmonary Disease Exacerbations and Novel Diagnostics: A Binational Prospective Cohort Study.
Wiseman DJ. et al, (2024), American journal of respiratory and critical care medicine, 210, 994 - 1001
A novel whole blood assay to quantify the release of T cell associated cytokines in response to Bordetella pertussis antigens.
Pinto MV. et al, (2024), Journal of immunological methods, 534
Changes to the UK childhood immunisation schedule.
Akeju O. et al, (2024), Archives of disease in childhood
Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050
Naghavi M. et al, (2024), The Lancet, 404, 1199 - 1226
Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021.
GBD 2021 Lower Respiratory Infections and Antimicrobial Resistance Collaborators None., (2024), The Lancet. Infectious diseases, 24, 974 - 1002
What have we learned from animal studies of immune responses to respiratory syncytial virus infection?
Drysdale SB. et al, (2024), Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 175
Genome-wide Association Study of Susceptibility to Respiratory Syncytial Virus Hospitalization in Young Children <5 Years of age.
Egeskov-Cavling AM. et al, (2024), The Journal of infectious diseases, 230, e333 - e341
Pneumococcal Carriage and Disease in Adults in England, 2011–2019: The Importance of Adults as a Reservoir for Pneumococcus in Communities
El Safadi D. et al, (2024), The Journal of Infectious Diseases
Computational mining of B cell receptor repertoires reveals antigen-specific and convergent responses to Ebola vaccination
Richardson E. et al, (2024), Frontiers in Immunology, 15
Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis.
Feng S. et al, (2024), Health Technol Assess, 28, 1 - 109
Implementation and adherence to regular asymptomatic testing in a COVID-19 vaccine trial.
Williams LR. et al, (2024), Vaccine
Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 controlled human infection study
Jackson S. et al, (2024), The Lancet Microbe, 5, 655 - 668
Towards paratyphoid control: the vital role of the challenge model
McCann N. et al, (2024), The Lancet, 403, 2780 - 2781
Immunogenicity and safety of beta variant COVID-19 vaccine AZD2816 and AZD1222 (ChAdOx1 nCoV-19) as primary-series vaccination for previously unvaccinated adults in Brazil, South Africa, Poland, and the UK: a randomised, partly double-blinded, phase 2/3 non-inferiority immunobridging study.
Costa Clemens SA. et al, (2024), The Lancet. Microbe
Inflammation of the Nasal Mucosa is Associated with Susceptibility to Experimental Pneumococcal Challenge in Older Adults
Urban BC. et al, (2024), Mucosal Immunology
Children with perinatally acquired HIV exhibit distinct immune responses to 4CMenB vaccine
Cotugno N. et al, (2024), JCI Insight, 9
The Impact of Infant Bacille Calmette-Guérin Vaccination on the Immunogenicity of Other Vaccines: A Randomized Exploratory Study.
Maytum A. et al, (2024), The Pediatric infectious disease journal
Multi-omics analysis reveals COVID-19 vaccine induced attenuation of inflammatory responses during breakthrough disease
Drury RE. et al, (2024), Nature Communications, 15
A phase 3 randomized controlled trial of a COVID-19 recombinant vaccine S-268019-b versus ChAdOx1 nCoV-19 in Japanese adults.
Iwata S. et al, (2024), Scientific reports, 14
Intravenous immunoglobulin treatment for encephalitis in children aged 6 months to 16 years: the IgNiTE RCT
Iro MA. et al, (2024), Efficacy and Mechanism Evaluation, 1 - 53
Typhoid conjugate vaccines: a step towards typhoid control
Shakya M. and Pollard AJ., (2024), The Lancet Global Health, 12, e535 - e536
Targeted metagenomics reveals association between severity and pathogen co-detection in infants with respiratory syncytial virus
Lin G-L. et al, (2024), Nature Communications, 15
Airway and Blood Monocyte Transcriptomic Profiling Reveals an Antiviral Phenotype in Infants With Severe Respiratory Syncytial Virus Infection.
Chappin K. et al, (2024), The Journal of infectious diseases, 229, S100 - S111
Evaluating the relationship between ciprofloxacin prescription and non-susceptibility in Salmonella Typhi in Blantyre, Malawi: an observational study.
Ashton PM. et al, (2024), The Lancet. Microbe, 5, e226 - e234
Host gene expression signatures to identify infection type and organ dysfunction in children evaluated for sepsis: a multicentre cohort study.
Schlapbach LJ. et al, (2024), The Lancet. Child & adolescent health
Impact of Subgroup Distribution on Seasonality of Human Respiratory Syncytial Virus: A Global Systematic Analysis.
Deng S. et al, (2024), The Journal of infectious diseases, 229, S25 - S33
Paediatric meningitis in the conjugate vaccine era and a novel clinical decision model to predict bacterial aetiology.
Ng M. et al, (2024), The Journal of infection
Respiratory Syncytial Virus-Associated Hospital Admissions by Deprivation Levels Among Children and Adults in Scotland.
Osei-Yeboah R. et al, (2024), The Journal of infectious diseases, 229, S61 - S69
Respiratory Syncytial Virus-Associated Hospitalization in Adults With Comorbidities in 2 European Countries: A Modeling Study.
Osei-Yeboah R. et al, (2024), The Journal of infectious diseases, 229, S70 - S77